X. Challenges and future directions in peripheral T‐cell lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|33|S1|56-61

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.33, Iss.S1, 2015-06, pp. : 56-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential of pralatrexate as a treatment of peripheral T-cell lymphoma

By Dondi Alessandra   Bari Alessia   Pozzi Samantha   Ferri Paola   Sacchi Stefano  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 711-718

Informa Healthcare

Access to resources Recommend Favorite

Beyond the Guidelines in the Treatment of Peripheral T-Cell Lymphoma: New Drug Development

By Chen Andy I.   Advani Ranjana H.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 4, 2008-04 ,pp. : 428-435

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Alemtuzumab/fludarabine: EBV-associated B-cell lymphoma in patients with peripheral T-cell lymphoma: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Natalizumab: First report of peripheral T cell lymphoma?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1416, 2012-01 ,pp. : 32-33

Adis International

Access to resources Recommend Favorite

Romidepsin: In the Treatment of T-Cell Lymphoma

By Yang Lily P.H.  

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1469-1480

Adis International

Access to resources Recommend Favorite